Sanofi

SNYleader

Sanofi is a French multinational pharmaceutical company anchored by blockbuster biologic Dupixent (co-developed with Regeneron) and one of the world's largest vaccine businesses.

⇄ Compare

產品與營收

產品營收佔比

營收結構 ($46.1B)

靜態數據（加載即時財務…）

Biopharma (55%)

Vaccines (18%)

General Medicines (18%)

Consumer Healthcare (9%)

業務部門構成與主要客戶

產品詳情

Dupixent30%

Blockbuster biologic for atopic dermatitis, asthma, and other inflammatory conditions

Vaccines (Sanofi Pasteur)20%

Flu vaccines, pediatric combinations, and Beyfortus (RSV)

General Medicines30%

Lantus insulin, Plavix, and mature drug portfolio

Specialty Care & Consumer20%

Rare disease treatments and consumer healthcare

供應鏈關係

合作夥伴

Regeneron Pharmaceuticals

Dupixent co-development and profit sharing

影響: Critical — Regeneron develops key drug

競爭對手

Pfizer Inc.

Vaccines and respiratory

影響: Medium — vaccine market competition

AstraZeneca

Respiratory and immunology

影響: Medium — overlapping therapeutic areas

宏觀與市場背景

제약 / 바이오行業新聞

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

近期催化劑

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

AI 分析

點擊「取得 AI 分析」以獲得 Sanofi 的 AI 供應鏈分析。

企業資訊

總部

Paris, France

成立時間

2004

員工人數

91,000+

官網

sanofi.com

行業概況 — 제약 / 바이오

行業新聞